Jefferies & Co uprades Bio-Reference Labs (Nasdaq: BRLI) from Hold to Buy. Price target increased from $26 to $30.
This article: 119 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE